Detalhe da pesquisa
1.
Quality of Life in Male Breast Cancer: Prospective Study of the International Male Breast Cancer Program (EORTC10085/TBCRC029/BIG2-07/NABCG).
Oncologist
; 28(10): e877-e883, 2023 10 03.
Artigo
Inglês
| MEDLINE | ID: mdl-37310797
2.
Time interval between diagnosis to treatment of breast cancer and the impact of health insurance coverage: a sub analysis of the AMAZONA III Study (GBECAM 0115).
Breast Cancer Res Treat
; 198(1): 123-130, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36586038
3.
Results of a survey study on health professionals' perceptions of tumor boards in Brazil.
Future Oncol
; 19(14): 1013-1020, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-37222176
4.
Moderately hypofractionated post-operative radiation therapy for breast cancer: preferences amongst radiation oncologists from countries in Latin America and the Caribbean.
Rep Pract Oncol Radiother
; 28(3): 340-351, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37795395
5.
Influence of physician's lifestyle on the prescription of healthy habits to breast cancer patients (LACOG 1218).
Support Care Cancer
; 30(5): 4399-4406, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-35102451
6.
Characteristics of patients diagnosed with cervical cancer in Brazil: preliminary results of the prospective cohort EVITA study (EVA001/LACOG 0215).
Int J Gynecol Cancer
; 32(2): 141-146, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34969827
7.
Perspectives on emerging technologies, personalised medicine, and clinical research for cancer control in Latin America and the Caribbean.
Lancet Oncol
; 22(11): e488-e500, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34735818
8.
Cancer control in Latin America and the Caribbean: recent advances and opportunities to move forward.
Lancet Oncol
; 22(11): e474-e487, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34735817
9.
The impact of sociodemographic factors and health insurance coverage in the diagnosis and clinicopathological characteristics of breast cancer in Brazil: AMAZONA III study (GBECAM 0115).
Breast Cancer Res Treat
; 183(3): 749-757, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-32728860
10.
The LACOG-0415 phase II trial: abiraterone acetate and ADT versus apalutamide versus abiraterone acetate and apalutamide in patients with advanced prostate cancer with non-castration testosterone levels.
BMC Cancer
; 19(1): 487, 2019 May 23.
Artigo
Inglês
| MEDLINE | ID: mdl-31122212
11.
PET-CT has low specificity for mediastinal staging of non-small-cell lung cancer in an endemic area for tuberculosis: a diagnostic test study (LACOG 0114).
BMC Cancer
; 19(1): 5, 2019 Jan 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30606144
12.
Planning cancer control in Latin America and the Caribbean.
Lancet Oncol
; 14(5): 391-436, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23628188
13.
Protocol for the development of a core outcome set and reporting guidelines for locoregional treatment in neoadjuvant systemic breast cancer treatment trials: the PRECEDENT project.
BMJ Open
; 14(4): e084488, 2024 Apr 19.
Artigo
Inglês
| MEDLINE | ID: mdl-38643011
14.
Real-World Evidence of Ribociclib Plus Aromatase Inhibitors as First-Line Treatment in Advanced Breast Cancer: The BrasiLEEira Study.
JCO Glob Oncol
; 10: e2300484, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38603658
15.
Health Services Access Inequalities in Brazil Result in Poorer Outcomes for Stage III NSCLC-RELANCE/LACOG 0118.
JTO Clin Res Rep
; 5(3): 100646, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38434771
16.
Inequalities in Pap smear screening for cervical cancer in Brazil.
Prev Med
; 57(4): 366-71, 2013 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-23827721
17.
Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial.
Lancet Oncol
; 13(4): 412-9, 2012 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-22373563
18.
Real-world data on triple-negative breast cancer in Latin America and the Caribbean.
Ecancermedicalscience
; 17: 1635, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-38414969
19.
Current Scenario of Clinical Cancer Research in Latin America and the Caribbean.
Curr Oncol
; 30(1): 653-662, 2023 01 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36661699
20.
Global Cancer Drug Development-A Report From the 2022 Accelerating Anticancer Agent Development and Validation Meeting.
JCO Glob Oncol
; 9: e2300294, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37944089